AIHLFOTCHealthcare · Drug Manufacturers - Specialty & Generic

Adcock Ingram Holdings Limited

$3.50+0.00%(+$0.00)

TickerSpark Score

69/100

Solid

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AIHLF research report →

52-Week Range100% of range

Low $2.45

Current $3.50

High $3.50

Companywww.adcock.co.za

Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It offers a portfolio of over-the-counter products, prescription medicines, and consumer products, as well as instrumentation and surgical products. The company also provides a range of pharmaceutical products, such as women's health, cannabidiol oil, antiretroviral, dermatology, central nervous system, respiratory, ophthalmology, generics, cardiovascular, pain, gastroenterology, energy supplements, colds and flu, personal care, feminine hygiene, digestive well-being, allergies, baby care, cough, food and nutrition supplements, vitamins, and minerals supplements.

CEO: Andrew Gideon Hall
IPO: 2014
HQ: Midrand, ZA

Price Chart

+42.86% · this period

Valuation

Market Cap: $624.32M
P/E: 12.79
P/S: 1.12
P/B: 1.88
EV/EBITDA: 10.22
Div Yield: 3.74%

Profitability

Gross Margin: 32.99%
Op Margin: 11.73%
Net Margin: 8.80%
ROE: 15.09%
ROIC: 13.81%

Growth & Income

Revenue: $9.76B · 1.22%
Net Income: $858.51M · 5.47%
EPS: $5.85 · 8.33%
Op Income: $1.08B
FCF YoY: -68.14%

Performance & Tape

52W High: $3.50
52W Low: $2.45
50D MA: $3.50
200D MA: $2.88
Beta: 0.50
Avg Volume: 6

Get TickerSpark's AI analysis on AIHLF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime